Recall this earlier post re anti-PD-1 antibody of MEDX/ONO: <A HREF="http://www.investorshub.com/boards/read_msg.asp?message_id=12391903" target="_blank">http://www.investorshub.com/boards/read_msg.asp?message_id=12391903</A> I believe the Honjo researcher referred to in the WSJ is, or was, with ONO.